We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,466
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.2%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ID
13051
DELISTED
PARTS iD, Inc.
ID
$17.9K ﹤0.01%
77,155
+63,638
+471% +$34.4K
APWC icon
13052
Asia Pacific Wire & Cable
APWC
$62.7M
$17.9K ﹤0.01%
+12,107
New +$17.9K
DMRA
13053
CALL
Damora Therapeutics
DMRA
$1.92B
$17.9K ﹤0.01%
+360
New +$19K
CLSD
13054
CALL
DELISTED
Clearside Biomedical
CLSD
$17.9K ﹤0.01%
1,147
-733
-39% -$14.2K
RVP icon
13055
CALL
Retractable Technologies
RVP
$20.7M
$17.9K ﹤0.01%
10,200
-1,300
-11% -$2.45K
CGRN
13056
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$17.9K ﹤0.01%
+13,421
New +$23.6K
NNVC icon
13057
NanoViricides
NNVC
$35.2M
$17.8K ﹤0.01%
15,205
-73,007
-83% -$98.5K
III icon
13058
CALL
Information Services Group
III
$250M
$17.8K ﹤0.01%
3,500
-9,200
-72% -$47.2K
ORIO
13059
CALL
Orion Digital Corp
ORIO
$20.1M
$17.8K ﹤0.01%
9,033
-9,534
-51% -$20.2K
IBCP icon
13060
PUT
Independent Bank Corp
IBCP
$850M
$17.8K ﹤0.01%
1,000
+500
+100% +$10.8K
IUSG icon
13061
PUT
iShares Core S&P US Growth ETF
IUSG
$33.9B
$17.8K ﹤0.01%
200
CULP icon
13062
PUT
Culp Inc
CULP
$42.1M
$17.7K ﹤0.01%
3,400
-1,500
-31% -$8.02K
ORN icon
13063
CALL
Orion Group Holdings
ORN
$402M
$17.6K ﹤0.01%
6,800
+200
+3% +$556
CHS
13064
DELISTED
Chicos FAS, Inc.
CHS
$17.6K ﹤0.01%
3,199
-1,126,029
-100% -$6M
XGN icon
13065
PUT
Exagen
XGN
$161M
$17.5K ﹤0.01%
+7,200
New +$18.6K
TIGR
13066
UP Fintech Holding
TIGR
$822M
$17.4K ﹤0.01%
5,232
-107,521
-95% -$397K
GLMD icon
13067
Galmed Pharmaceuticals
GLMD
$4.32M
$17.4K ﹤0.01%
+227
New +$24.4K
HBB icon
13068
PUT
Hamilton Beach Brands
HBB
$448M
$17.4K ﹤0.01%
+1,700
New +$20.6K
LFCR icon
13069
PUT
Lifecore Biomedical
LFCR
$179M
$17.4K ﹤0.01%
4,600
-2,100
-31% -$11.7K
FHTX icon
13070
PUT
Foghorn Therapeutics
FHTX
$372M
$17.4K ﹤0.01%
2,800
+500
+22% +$3.27K
GLBS icon
13071
PUT
Globus Maritime Ltd
GLBS
$78.6M
$17.4K ﹤0.01%
15,500
-24,200
-61% -$27.8K
CBD
13072
PUT
DELISTED
Companhia Brasileira de Distribuicao
CBD
$17.3K ﹤0.01%
+5,900
New +$19.1K
SEF icon
13073
PUT
ProShares Short Financials
SEF
$12.9M
$17.3K ﹤0.01%
+325
New +$16.5K
ORKA
13074
CALL
Oruka Therapeutics
ORKA
$7.35B
$17.3K ﹤0.01%
725
-308
-30% -$8.12K
OR icon
13075
OR Royalties Inc
OR
$6.25B
$17.2K ﹤0.01%
1,090
-35,546
-97% -$479K

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.